Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modifying muscle mass - the endocrine perspective.

A M Solomon1, P M G Bouloux

  • 1Department of Endocrinology, Royal Free Hospital and Medical School, Pond Street, London NW3 2PF, UK. a.solomon@medsch.ucl.ac.uk

The Journal of Endocrinology
|November 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nasally located ectopic ACTH-secreting pituitary adenoma (EAPA) causing Nelson's syndrome: diagnostic challenges.

Pituitary·2013
Same author

Genetic analysis of NR0B1 in congenital adrenal hypoplasia patients: identification of a rare regulatory variant resulting in congenital adrenal hypoplasia and hypogonadal hypogonadism without testicular carcinoma in situ.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation·2012
Same author

What is the optimal therapy for young males with hypogonadotropic hypogonadism?

Clinical endocrinology·2009
Same author

GnRH-I and GnRH-II have differential modulatory effects on human peripheral blood mononuclear cell proliferation and interleukin-2 receptor gamma-chain mRNA expression in healthy males.

Clinical and experimental immunology·2005
Same author

Expression of gonadotropin-releasing hormone type-I (GnRH-I) and type-II (GnRH-II) in human peripheral blood mononuclear cells (PMBCs) and regulation of B-lymphoblastoid cell proliferation by GnRH-I and GnRH-II.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2004
Same author

The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity.

The Journal of endocrinology·2003
Same journal

Chronic hyperinsulinemia accelerates adipose senescence via mitochondrial dysfunction and cGAS-STING signalling.

The Journal of endocrinology·2026
Same journal

Probiotic Lactobacillus reuteri KUB-AC5 provides cardioprotection via mitigating cardiac mitochondrial dysfunction in obese rats.

The Journal of endocrinology·2026
Same journal

Relationship between hypothalamic astrocytes and gonadotropin-releasing hormone neurons in the female plains vizcacha.

The Journal of endocrinology·2026
Same journal

Passive exercise failed to reverse OVX-induced bone microstructural degeneration to the extent achieved by HRT.

The Journal of endocrinology·2026
Same journal

Downregulation of SLC32A1 mediates the PAI-1 pathway in alleviating hepatic stellate cell activation and liver fibrosis.

The Journal of endocrinology·2026
Same journal

Triiodothyronine-driven pro-inflammatory responses of dendritic cells are restrained by sphingolipid signaling.

The Journal of endocrinology·2026
See all related articles

This review explores hormonal factors influencing muscle growth and loss, highlighting satellite cells and novel therapeutic targets like myostatin for combating age-related sarcopenia.

Area of Science:

  • Endocrinology
  • Muscle Physiology
  • Molecular Biology

Background:

  • Skeletal muscle mass is regulated by hormonal factors influencing anabolism and catabolism.
  • Age-related muscle loss (sarcopenia) is a significant health concern with complex underlying mechanisms.
  • Satellite cells play a crucial role in muscle hypertrophy and are influenced by local endocrine factors.

Purpose of the Study:

  • To review the major hormonal factors governing skeletal muscle anabolism and catabolism.
  • To examine the molecular mechanisms of muscle hypertrophy and atrophy, focusing on sarcopenia.
  • To discuss novel endocrine mechanisms and potential therapeutic targets for muscle wasting.

Main Methods:

  • Literature review of hormonal regulation in skeletal muscle.

Related Experiment Videos

  • Analysis of molecular pathways involved in muscle hypertrophy and atrophy.
  • Examination of the role of satellite cells and endocrine factors in muscle dynamics.

    • Main Results:

    • Hormonal factors critically determine the balance between muscle protein synthesis and breakdown.
    • Satellite cell dynamics are modulated by local endocrine signals, impacting muscle repair and growth.
    • Mechanisms of muscle atrophy and hypertrophy may not be simple opposites; novel pathways like IGF-I subtypes are involved.
    • Myostatin is identified as a key negative regulator of muscle mass with therapeutic potential.

    Conclusions:

    • Hormonal regulation is central to maintaining skeletal muscle mass and function throughout life.
    • Understanding satellite cell biology and endocrine influences is key to addressing sarcopenia.
    • Targeting pathways like myostatin offers promising therapeutic strategies for age-related muscle loss and other muscle disorders.